Corin expanded its distribution agreement with FX Solutions to include U.S. marketing of the Humelock™ II Cementless and Cemented Anatomical and Reversible Shoulder Systems, plus additional products pending FDA clearance. Previously, the agreement was limited to Germany and the U.K.
The Humelock cemented shoulder received FDA 510(k) clearance in 2011; FX had acquired the technology from Small Bone Innovations in 4Q10.
Corin’s other recent joint recon activity includes its acquisition of Tornier’s large joint assets from Wright Medical.
Corin expanded its distribution agreement with FX Solutions to include U.S. marketing of the Humelock™ II Cementless and Cemented Anatomical and Reversible Shoulder Systems, plus additional products pending FDA clearance. Previously, the agreement was limited to Germany and the U.K.
The Humelock cemented shoulder received FDA 510(k) clearance...
Corin expanded its distribution agreement with FX Solutions to include U.S. marketing of the Humelock™ II Cementless and Cemented Anatomical and Reversible Shoulder Systems, plus additional products pending FDA clearance. Previously, the agreement was limited to Germany and the U.K.
The Humelock cemented shoulder received FDA 510(k) clearance in 2011; FX had acquired the technology from Small Bone Innovations in 4Q10.
Corin’s other recent joint recon activity includes its acquisition of Tornier’s large joint assets from Wright Medical.
Copy to clipboard 
